Using Virtual Reality and Simple Computer Tasks To Understand Recovery in People Struggling with Alcohol Use.

Evaluating the Association of Addictions Neuroclinical Assessments based Measures with Treatment Outcomes and their Change following Virtual Reality Cue Exposure In Individuals with Alcohol Use Disorder - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108406

Enrollment

Registered

2026-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence

Interventions

Intervention1: Virtual Reality Cue Exposure (VRCE): Multiple sessions of VRCE will be administered to experiment group where they will be exposed to alcohol related cues such as rooms with alcohol bot

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of Alcohol Use Disorder (AUD) as per DSM-5 criteria, Currently admitted to the inpatient psychiatry unit at AIIMS Bhopal, Able to understand instructions and perform computerized tasks in Hindi or English, None or mild alcohol withdrawal at the time of assessment Willing and able to provide written informed consent, Willing and eligible for disulfiram as a pharmacological treatment at the time of discharge.

Exclusion criteria

Exclusion criteria: 1. Comorbid psychiatric disorders (e.g., schizophrenia, bipolar disorder) or other substance use disorders, excluding nicotine 2. Comorbid neurological conditions that interfere with computerized assessment or VR use (e.g., epilepsy, traumatic brain injury, seizure disorders) 3. Severe cognitive impairment (as determined by clinical judgment or documented history) that prevents meaningful task engagement 4. Visual or motor impairments that limit the ability to interact with computerized or VR-based tasks 5. Current use of medications or medical conditions that may significantly affect cognitive functioning (e.g., delirium, heavy sedation) 6. Current use of medications or medical conditions that can affect craving (e.g., Naltrexone, Baclofen etc. ) 7. History of severe motion sickness/vertigo, severe migraine triggered by visual stimuli

Design outcomes

Primary

Measure	Time frame
The primary treatment outcome that will be measured is Craving via the Penn Alcohol Craving Scale (PACS).Timepoint: 4-week follow-up post discharge (+/- 1 week)	—

Secondary

Measure	Time frame
Pattern of Alcohol Consumption, coping, readiness etc via TLFB, RCQ, semi structured proforma, Brief Cope Scale etcTimepoint: same as primary outcome, i.e. 4 week post discharge	—

Countries

India

Contacts

Public ContactAnanya Mishra

AIIMS Bhopal

vijender.psy@aiimsbhopal.edu.in9810930723

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026